| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.4192 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.4949 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.5097 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.5530 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.5580 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.5739 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.5849 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6093 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6096 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6128 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6136 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6274 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6308 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6464 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6511 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6607 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6642 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6645 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6708 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6762 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6823 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6842 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6845 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6891 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6894 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6956 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.6993 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7036 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7113 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7264 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7294 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7313 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7314 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7342 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7415 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7430 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7444 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7450 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7543 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7570 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7583 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7640 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7761 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7792 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.7965 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8025 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8032 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8105 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8121 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8164 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8228 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8287 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8289 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8307 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8406 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8410 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8432 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8488 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8550 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8588 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8613 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8675 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8742 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8768 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8878 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8911 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8916 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8926 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8928 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.8949 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9015 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9020 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9073 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9092 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9137 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9201 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9243 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9326 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9336 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9365 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9423 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9427 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9579 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9650 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9708 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9745 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9787 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9788 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9831 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9861 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9871 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9907 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 0.9993 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0000 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0007 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0010 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0079 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0111 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0139 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0177 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0242 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0250 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0310 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0313 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0336 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0398 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0418 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0467 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0470 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0497 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0541 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0620 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0658 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0694 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0722 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0728 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0830 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0944 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.0952 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1175 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1257 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1328 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1346 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1351 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1493 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1573 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1647 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1653 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1720 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1753 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1793 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.1851 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2001 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2117 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2121 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2159 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2215 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2221 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2270 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2330 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2386 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2407 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2521 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2525 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2567 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2580 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2687 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2695 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2869 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2886 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2937 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2953 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.2974 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3040 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3064 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3091 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3150 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3308 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3425 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3489 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3532 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3672 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3726 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.3736 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4010 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4078 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4100 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4199 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4217 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4219 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4285 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4330 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4368 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4415 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4422 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4589 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4596 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.4847 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.5316 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.5426 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.5479 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.5546 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.5562 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.6247 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.6398 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.6487 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylputrescine | 1.8750 | scaled units | Low-Dose | BASELINE |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|